Welcome to NDF Research
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog
2019 Red Hat Award winners
By Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909 (26 July 2019)
Picture
The Bioshares Biotech Summit is arguably one of the world's best Life Sciences investment conferences. Traditionally at Bioshares, held every winter in Queenstown, New Zealand, there has been an opening night dinner for the CEOs of biotech and medical device companies who are attending. Beginning in 2014 the rest of us have had our own get-together, which we call the Peasants Dinner. The 2019 Peasants Dinner was held on Thursday 25 July 2018 at Prime, 8 Rees Street Queenstown. This year 95 Peasants attended, making it a really great night. Peasants gives the Life Sciences community of Australia and New Zealand a chance to acknowledge some of its rock stars through the annual Red Hat Awards, which represents significant contributions to the growth of the sector by the rank and file. Here are the 2019 Red Hat Award winners. For previous years' winners click here.

Stephen Earl

Founder, Acuity Capital
Financier of the Year
Picture
Stephen Earl is one of the great disrupters of our era from a capital market perspective. The Controlled Placement Agreements which his firm, Acuity Capital, markets to ASX-listed Life Science companies allows those companies to sidestep the broker community completely and raise as much capital as they need at the market price of the stock, so long as that stock is liquid. This revolutionary approach promises great outcomes for companies that are willing to market their stock and not leave that task to brokers who will never understand it as well as company management will. Stephen Earl, a lawyer by background, founded Acuity Capital in 2012 to bring the CPA approach to Australia. Steve has gone about the task of selling his CPAs with the dogged determination.

Lee Rochester

Principal, Wexford Hayes
Kiwi of the Year
Picture
Lee Rochester is one of those helpful people in the biotech and medical device industry who know where to find good talent to build great companies. He currently does that in Sydney, but Lee still calls New Zealand home, having gone to Hutt Valley High School in Wellington followed by Massey University in Palmerston North. Lee has spent just about all his working life in talent sourcing in fields as diverse as financial services and infrastructure, but he has evolved in recent years a strong specialty in Life Sciences. Lee’s practice at Wexford Hayes, where he is a Client Partner, is a great source of information on recruitment issues in healthcare.

Nick Ede

Chief Technologhy Officer, Imugene Ltd
​​Cage Rattler of the Year
Picture
Many people in the biotech and medical device industry have only one company in them, either through lack of imagination or energy, or through the narrowness of their training. The real ‘cage rattlers’ are the professionals who can make a serious contribution in multiple kinds of companies, across different treatment paradigms and disease conditions. Dr Nick Ede is one such cage rattler for the biotech industry in Australia. Nick didn’t settle for just being a leading authority on peptide synthesis when he ran Mimotopes, he went on to invent a potential new treatment for snoring and sleep apnea at Consegna, and since 2013 he’s contributed to major advances in the field of cancer immunotherapy at Imugene, where he is currently Chief Technology Officer. It’s fair to say that with Nick there’s always plenty of fuel in the tank. 

Lorraine Chiriou

CEO, AusBiotech
Best New Peasant
Picture
Lorraine Chiroiu took the helm at Australia’s peak lobby group for the biotech industry in July 2018. Her educational background isn’t science or medicine, but public relations, which is what our industry could use more of. In Lorraine’s ten years with AusBiotech, first as Chief Industry Affairs Officer and then as Deputy CEO, the sector has had to head off numerous challenges to public funding as successive Federal and state governments question the benefits of backing new ventures that may takes years to give back to the public’s coffers. It’s comforting to know that people like Lorraine are there to remind the politicians and bureaucrats as well as the taxpayers that companies like Cochlear and Resmed is what we are good at Down Under.

Craig Hadfield

CFO, Volpara Solutions
​Best Re-Rating, 2019
Picture
Craig Hadfield, a mild-mannered accountant who hails from Johannesburg and did his basic training at Wits University, arrived in the New Zealand capital in 2014 and did a couple of years at Deloitte there before joining Volpara in mid-2016, initially as Financial Controller, then as CFO. At the time Hadfield signed on Volpara stock, newly listed on the ASX, was under 40 cents. It’s since been over $1.80. Volpara has had a great few years as the company expands the reach of its breast imaging analytics and analysis products to the US and multiple other markets.

Janette Dixon

Founder, Just Partnering
​First Lady
Picture
A long time ago Dr. Janette Dixon was a medical laboratory scientist, but she has since gone in a number of different directions, including restructuring of New Zealand’s largest pharmaceutical manufacturer, building a diagnostics and drug development companies in Southeast Asia and consulting to various drug development projects. Janette is a proud Kiwi but also calls Thailand and Singapore home.

Jane Lowe

Founder, IR Department
Hall of Fame
Picture
One of the great blessings for investors and analysts interested on the biotech and medical device industry Down Under is the quality of the Investor Relations specialists who serve them. One of the best in the business is Jane Lowe. When you get a call from Jane or her colleagues at the IR Department asking you to look at one of her biotech clients, you know that she’s done her homework on the company, and that, if the company takes her advice, it is on the way to greatness. Jane combines great professional skills with unique personal charm and everyone who works with her or for her only ever has nice things to say about her. Indeed, even her competitors think she’s great. Over the years Jane has been a strong advocate for women in the biotech sector in Australia and New Zealand, and this year at Peasants we honour her as one of the sector’s great assets.

Copyright © 2019 NDF Research
Proudly powered by Weebly
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog